NLRP3 and Alzheimer disease: Inhibiting the TLR4/NF-κB/NLRP3 signaling pathway can induce M2 microglial polarization in patients with AD, which reduces neuroinflammation and improves learning and memory disorders (Cui et al., 2020; Yan et al., 2020).